Abstract
We report a case of Chinese FCCM and its associated symptoms with CCM1-deletion mutations in China. Our findings deepen our understanding of CCM mutations and related phenotypes, the investigation results of this clinical experiment further show that the gene mutation form we reported plays an important role in human FCCM, and this trial investigation is beneficial for genetic counseling for CCM patients.
Introduction
Cerebral Cavernous Malformations (CCMs) are vascular anomalies in the brain and spinal cord that look like "popcorn" or "mulberries" on imaging. They can cause headaches, seizures, and life-threatening hemorrhagic strokes. While most cases are sporadic, about 20% are familial (FCCM), linked to mutations in three genes: CCM1, CCM2, and CCM3.
The challenge lies in the disease's "incomplete penetrance." A person can inherit the mutated gene but show no symptoms, or have multiple brain lesions that remain "silent" until a sudden bleed occurs. Furthermore, data on the specific genetic landscape of FCCM in Chinese populations is relatively sparse compared to Western cohorts. This paper aims to bridge that gap by documenting a novel family case and reviewing the last decade of Chinese clinical literature on the subject.
Methods and Pedigree Analysis
The researchers conducted a comprehensive clinical and genetic investigation of an 11-member Chinese family. Their approach combined traditional clinical neurology with modern genomic tools:
- Pedigree Analysis: They mapped three generations to track the inheritance pattern, confirming an autosomal dominant mode of transmission.
- Neuroimaging: Magnetic Resonance Imaging (MRI) was used to identify intracranial lesions. The team specifically noted the importance of T2-weighted and fluid-attenuated sequences to find the characteristic "hemosiderin ring" (a stain left by old blood).
- Genetic Sequencing: Genomic DNA was extracted from peripheral blood. The team used Polymerase Chain Reaction (PCR) to amplify all coding exons of the CCM1, CCM2, and CCM3 genes.
Key Results: Identification of the CCM1 Mutation
The team identified a specific heterozygous frameshift mutation in exon 14 of the CCM1 gene (c.1362_1363del). This "frameshift" mutation shifts the genetic reading frame, creating a premature stop codon (p.Gln455fs). This results in a truncated, non-functional protein, which likely destabilizes the vascular lining in the brain.
The CCM1 mutation was found in the proband and all family members who showed lesions on MRI. Out of the family members studied, several required neurosurgery due to repeated hemorrhages. The proband himself had undergone two craniotomies over 20 years.
Discussion and Clinical Implications
A major insight from the study is the discrepancy between imaging and symptoms, known as radiological vs. clinical penetrance. For example, the proband’s son had multiple lesions on his MRI but remained asymptomatic. This underscores that a "clean" clinical history does not rule out the presence of dangerous vascular malformations.
The paper emphasizes that standard MRI sequences might miss small lesions. They suggest that gradient-echo sequences are far more sensitive for detecting the multiple, small "Type 4" lesions often found in mutation carriers. Even within the same family sharing the exact same mutation, symptoms varied wildly—from blurred vision and stuttering to total absence of symptoms.
Limitations and Future Work
The primary limitation is that this is a single-family case study. While it provides deep insights into this specific mutation, it cannot account for the full genetic diversity of FCCM across the entire Chinese population. Future work should involve more systematic screening of suspected families and potentially functional studies to understand why some carriers remain asymptomatic while others suffer severe hemorrhages. Early detection via genetic testing remains the most vital tool for clinical intervention, as the risk of bleeding increases significantly after the first event.
Summary updated